ANGELA LINCOLN: Open Payments
NPI 1134837032 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 33 payments from 15 companies in 2025. Trend: 2023 $15 · 2024 $166 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $148 |
| Exact Sciences Corporation | 4 | $85 |
| Lilly USA, LLC | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 3 | $64 |
| Seqirus USA Inc | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| PFIZER INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, ZORYVE, AIRSUPRA, MOUNJARO, FARXIGA, Ozempic, Fluad.
Industry payments across TX — which companies pay providers there.
